These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15786765)

  • 1. [Expression of the cerbB-2 (HER-2/neu) oncoprotein in prostatic adenocarcinoma].
    San Miguel Fraile P; Dos Santos JE; Pélaez Boismorand E; Ortiz Rey JA; Iglesias Rodríguez B; Cambronero Santos J; Fajardo Seijo JL; Rodríguez Costas JM; Fernández Regueiro M
    Actas Urol Esp; 2005 Jan; 29(1):64-9. PubMed ID: 15786765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.
    Sanchez KM; Sweeney CJ; Mass R; Koch MO; Eckert GJ; Geary WA; Baldridge LA; Zhang S; Eble JN; Cheng L
    Cancer; 2002 Oct; 95(8):1650-5. PubMed ID: 12365012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HER-2/neu in patients with prostatic adenocarcinoma.
    Zahir ST; Tafti HF; Rahmani K
    Asian Pac J Cancer Prev; 2014; 15(15):6425-8. PubMed ID: 25124637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
    Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW
    J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
    Hasby EA; Saied EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
    Gu K; Mes-Masson AM; Gauthier J; Saad F
    Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.
    Fosså A; Lilleby W; Fosså SD; Gaudernack G; Torlakovic G; Berner A
    Int J Cancer; 2002 May; 99(1):100-5. PubMed ID: 11948499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.
    Ibrahim GK; MacDonald JA; Kerns BJ; Ibrahim SN; Humphrey PA; Robertson CN
    Surg Oncol; 1992 Apr; 1(2):151-5. PubMed ID: 1285216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer.
    Morote J; de Torres I; Caceres C; Vallejo C; Schwartz S; Reventos J
    Int J Cancer; 1999 Aug; 84(4):421-5. PubMed ID: 10404097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
    Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
    Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.
    Mydlo JH; Kral JG; Volpe M; Axotis C; Macchia RJ; Pertschuk LP
    Eur Urol; 1998; 34(5):426-32. PubMed ID: 9803006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
    Sadasivan R; Morgan R; Jennings S; Austenfeld M; Van Veldhuizen P; Stephens R; Noble M
    J Urol; 1993 Jul; 150(1):126-31. PubMed ID: 7685420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of HER-2/NEU-CERBB-2 in patients with adenocarcinoma of the stomach.
    Cirne-Lima FK; Rosa Ade S; Kulczynski JM; Mattana DS; Corezolla K; Moreira LF
    Rev Col Bras Cir; 2009 Apr; 36(2):131-4. PubMed ID: 20076883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
    De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
    Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis.
    Ross JS; Nazeer T; Church K; Amato C; Figge H; Rifkin MD; Fisher HA
    Cancer; 1993 Nov; 72(10):3020-8. PubMed ID: 8106140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
    Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
    Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
    Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
    BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.